The rest-frame UV-optical (i.e., NUV − B) color index is sensitive to the low-level recent star formation and dust extinction, but it is insensitive to the metallicity. In this Letter, we have measured the rest-frame NUV − B color gradients in ∼1400 large (r e > 0 18), nearly face-on (b/a > 0.5) main sequence star-forming galaxies (SFGs) between redshift 0.5 and 1.5 in the CANDELS/GOODS-S and UDS fields. With this sample, we study the origin of UV-optical color gradients in the SFGs at z ∼ 1 and discuss their link with the buildup of stellar mass. We find that the more massive, centrally compact, and more dust extinguished SFGs tend to have statistically more negative raw color gradients (redder centers) than the less massive, centrally diffuse, and less dusty SFGs. After correcting for dust reddening based on optical-spectral energy distribution fitting, the color gradients in the low-mass (M * < 10 10 M e ) SFGs generally become quite flat, while most of the high-mass (M * > 10 10.5 M e ) SFGs still retain shallow negative color gradients. These findings imply that dust reddening is likely the principal cause of negative color gradients in the low-mass SFGs, while both increased central dust reddening and buildup of compact old bulges are likely the origins of negative color gradients in the high-mass SFGs. These findings also imply that at these redshifts the low-mass SFGs buildup their stellar masses in a self-similar way, while the high-mass SFGs grow inside out.
Background: The potential association between hepatitis B virus (HBV) infection and development of osteoporosis has drawn significant attention from clinicians and researchers in recent years due to the increasing prevalence of HBV infection. This study aims to perform a systematic review and meta-analysis of the literature to show whether HBV infection is associated with an increased risk of osteoporosis.Methods: Case-control, cohort, and cross-sectional studies that report the incidence of osteoporosis, osteoporotic fracture, osteopenia, and bone mineral density level in populations with HBV infection will be selected. Four databases from their inception to October 2019 will be searched. All data were assessed and extracted by 2 authors independently. The Newcastle-Ottawa scale and (Agency for Healthcare Research and Quality) Agency for Healthcare Research and Quality checklist will be used to assess the quality of the selected studies. Stata 15.1 (Stata Corp, College Station, TX) will be used to conduct meta-analysis.Result: The results of this systemic review and meta-analysis will be submitted to a recognized journal for publication. Conclusion:This systemic review and meta-analysis will determine whether HBV infection is associated with an increased risk of osteoporosis. We hope this review can provide a reliable evidence.
Background: Acupoint injection has currently received increasing attention as a treatment for primary osteoporosis (POP), This study aimed to evaluate the efficacy and safety of acupoint injection as a clinical treatment for POP.Methods: Randomized controlled trials (RCTs) of acupoint injection compared with conventional nonacupoint injection for POP were identified in searches of seven databases from their inception to March 2019. All data were assessed and extracted by two authors independently. The risk of bias assessment recommended by the Cochrane Collaboration was used to assess the quality of the selected studies. RevMan 5.3 was used to conduct meta-analysis for the efficacy and safety of acupoint injection.Results: Five trials with 337 patients (aged 45-86 years) with bone mineral density (BMD) ≤2 SD were included in our meta-analysis. The results showed that, compared with conventional intramuscular injection, acupoint injection significantly increased the BMD [mean difference (MD) =0.02; 95% CI, 0.01 to 0.03, P<0.00001]. Subgroup analysis indicated that acupoint injection significantly improved lumbar BMD (MD =0.02; 95% CI, 0.01 to 0.03, P<0.00001) but did not reduce the pain score (SMD =−2.29, 95% CI, −6.81 to 2.23, P>0.05). Individuals results showed that acupoint injection improved biochemical indicators, such as NBAP, IGF-I and reduced CTX and leptin levels. While the risk of bias was high in all five trials.Conclusions: This meta-analysis and systematic review suggests that acupoint injection improves BMD and some biochemical indicators in POP patients compared with the effects of conventional intramuscular injection. However, due to the high risk of bias in all the trials reviewed, the evidence remains inconclusive and future research will be required with improved methodological quality.
Starting with the ingot with a nominal stoichiometric composition of SmCo9.8, the nanocrystalline bulk with ultrafine nanograin structure was prepared by a route combing ball milling and spark plasma sintering. The phase formation, microstructure, crystal lattice characteristics, and magnetic performance of the nanocrystalline SmCo9.8 alloy were investigated. The TbCu7-type solid solution of the SmCo9.8 composition was obtained, and the crystal structure of the nanocrystalline 1:9.8 H was constructed. The magnetic features were disclosed through nanostructuring to obtain the single metastable 1:9.8 H. It was found that the nanocrystalline SmCo9.8 alloy has high saturation magnetization and Curie temperature. The study presents a new understanding of the nanoscale-stabilized TbCu7-type solid solution of the SmCo9.8 composition and may promote the development of SmCo9.8-type alloys as candidates for the high-temperature permanent magnets, based on the coercivity improvement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.